Date: April 20th at 1:00 pm (BJT) / 2:00 pm (KST / JST) / 7:00 am CET
Submitting an IND application to the US FDA is a significant step in the development of a new drug or biologic product. But, are you ready? Attend this seminar to understand how to make sure your next IND meets FDA requirements and gets a “Safe to Proceed” letter from the FDA within 30 days from submission. This virtual seminar contains a collection of everything you need to know to determine whether you are ready to submit your IND and take the next step in the development of your product.